Percutaneous Electrolysis, Ultrasound-guided Percutaneous Neuromodulationtherapy and Eccentric Exercise in Supraspinatus Tendinopathy.
Supraspinatus Tendinitis
About this trial
This is an interventional treatment trial for Supraspinatus Tendinitis focused on measuring tendinopathy, electrolysis, exercise, dry needling
Eligibility Criteria
Inclusion Criteria: Patients diagnosed with supraspinatus tendinopathies that do not improve with conventional physiotherapy or pharmacological therapy protocols. Subjects who are in an active state of pain, who present painful symptoms in a sensitive and painful area of the tendon of insertion of the supraspinatus muscle in the humerus. Exclusion Criteria: Individuals who have received surgery intervention in the same shoulder, or have suffered fractures or dislocations in the same shoulder. Individuals have received the proposed treatment in one month´s period previously. Individuals who suffering from cervical radiculopathies, fibromialgia síndrome, cardiac patients with pacemakers, cancer, infectious processes, or generalized lymphedema. Pregnant women can not receive this treatment intervention.
Sites / Locations
- Policlínica Santa María
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Percutaneous Electrolysis and neuromodulation.
Control group
The intervention for this group consisted of Therapeutic Percutaneous Electrolysis and neuromodulation. Patient received once week for four weeks associated with eccentric exercises device at home.
The multimodal physical therapy program includes 10 sessions of: Ultrasound pulsatil therapy (US) for 10 minutes , transcutaneous electric nerve stimulation (TENS) for 20 minutes ans associated with eccentric exercises device at home.